Carvana CEO Garcia sells $3.65 million in shares

Carvana CEO Ernest C. Garcia III indirectly sold $3.65 million in company stock on September 15, 2025, via a 10b5-1 plan, following a 127% six-month stock surge and near its 52-week high. This insider transaction occurs despite Carvana reporting strong Q2 2025 adjusted EBITDA of $601 million, which exceeded analyst expectations and led to multiple price target upgrades from firms like JPMorgan and Citizens JMP; however, InvestingPro analysis indicates the company is currently overvalued at an $82.5 billion market capitalization.

Analysis

Carvana's recent operational performance presents a strong bullish case, contrasted by valuation concerns and insider selling activity. The company reported second-quarter 2025 adjusted EBITDA of $601 million, decisively beating both JPMorgan’s ($530M) and Bloomberg’s consensus ($551M) estimates. This robust earnings report triggered a series of positive analyst actions, including JPMorgan raising its price target to $425 while maintaining an Overweight rating, and Citizens JMP reiterating a Market Outperform rating with a $460 target. However, this positive fundamental news is juxtaposed with the indirect sale of $3.65 million in stock by CEO Ernest C. Garcia III. While the transaction was executed under a pre-arranged Rule 10b5-1 plan and the CEO retains significant holdings, it occurred as the stock trades near its 52-week high after a 127% surge over six months. This rapid appreciation has led to an $82.5 billion market capitalization, which an InvestingPro analysis suggests is currently overvalued.

Key Decisions for Investors

• Investors should weigh the strong fundamental momentum, evidenced by the significant Q2 EBITDA beat and multiple analyst price target upgrades, against potential valuation risks following the stock's 127% six-month rally.
• The CEO's $3.65 million stock sale, while a potential cautionary signal, should be contextualized by its execution under a pre-scheduled 10b5-1 plan and the substantial remaining stake held, which may mitigate its negative implications.
• Given the conflicting signals of strong operational performance versus high valuation and insider selling, it may be prudent to monitor for any deceleration in growth metrics in subsequent quarters before increasing a position.